We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

005830:KRXDB INSURANCE CO. LTD Analysis

Data as of 2026-03-14 - not real-time

₩177,300.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

DB Insurance trades at KRW 177,300, comfortably above its 50‑day SMA (KRW 154,562) and 200‑day SMA (KRW 133,898) but below the 20‑day SMA (KRW 185,955), indicating a short‑term pull‑back within a longer‑term bullish framework. The stock’s forward P/E of 5.9 is dramatically lower than the industry average of 16.3, while the price‑to‑sales multiple sits at 0.54, underscoring a pronounced valuation discount. A dividend yield of 4.29% with a modest 25.6% payout ratio, backed by strong free cash flow (KRW 777 bn) and a massive cash pile (KRW 41.5 trn), points to a sustainable income stream. The DCF model suggests a fair value near KRW 805 k, implying roughly 19% upside from current levels, and the Fear‑Greed Index at 72.9 signals market optimism. However, the 30‑day volatility of 66.8% and a bearish MACD histogram highlight near‑term price turbulence, while recent activist shareholder letters from Align Partners flag governance and capital‑allocation concerns.
Overall, the combination of deep valuation discounts, solid dividend fundamentals, and a low‑beta profile (0.52) makes DB Insurance an attractive value play, though investors should monitor short‑term technical weakness and potential boardroom developments that could affect momentum.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below 20‑day SMA suggesting limited upside
  • Bearish MACD histogram indicating possible further pull‑back
  • Activist shareholder activity could create short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant valuation gap vs industry (PE 5.9 vs 16.3)
  • Projected 19% upside from DCF fair value
  • Attractive dividend yield with sustainable payout

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong cash position and positive free cash flow
  • Low beta and defensive insurance sector exposure
  • Consistent dividend income supporting total return

Key Metrics & Analysis

Financial Health

Revenue Growth-6.30%
Profit Margin8.03%
P/E Ratio5.9
ROE16.00%
ROA1.82%
Debt/Equity36.57
Op. Cash Flow₩-585291202560
Free Cash Flow₩776.7B
Industry P/E16.4

Technical Analysis

TrendBullish
RSI51.8
Support₩167,300.00
Resistance₩214,000.00
MA 20₩185,955.00
MA 50₩154,562.00
MA 200₩133,898.00
MACDBearish
VolumeStable
Fear & Greed Index72.88

Valuation

Fair Value₩805,131.28
Target Price₩211,315.80
Upside/Downside19.19%
GradeUndervalued
TypeValue
Dividend Yield4.29%

Risk Assessment

Beta0.52
Volatility66.78%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.